H. Onyuksel
Biomaterials · 2005
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Biomaterials — 14 citations into it
- Molecular Biology — 14 citations into it
- Pharmaceutical Science — 5 citations into it
Whom H. Onyuksel trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from H. Onyuksel's perspective
Ordered by how strongly the researchers H. Onyuksel trusts endorse each paper. Same corpus, a different order for every researcher.
- Nanocrystal targeting in vivo (Proceedings of the National Academy of Sciences of the United States of America)
- Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor (Pharmaceutical Research)
- Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. (European Journal of Cancer)
- Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. (Clinical Cancer Research)
- Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. (Journal of Controlled Release)
- Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. (Progress in lipid research)
- Nanotech approaches to drug delivery and imaging. (Drug Discovery Today)
- Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
- Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. (Clinical Cancer Research)
- The blood-brain barrier: an overview: structure, regulation, and clinical implications. (Neurobiology of Disease)
Their papers
- Role of nanotechnology in targeted drug delivery and imaging: a concise review. (2005) — 707 citations